Search results | evaluation

Reports

Option and Evaluation Agreements in Pharma and Biotech

The Option and Evaluation Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies.

Insights

Packaging your offering – Option and evaluation agreements

CP Insight > Insight Toolkit > Finding Partners > Packaging your offering – Option and evaluation agreements At a certain stage after initial evaluation of partnering opportunities, the potential licensee company may seek to exclude competitors from evaluating the opportunity for a set period of time, or enter into an option agreement that provides the licensee company with first refusal on a more »

Evaluation

Evaluation agreements allow a party to the deal to obtain rights to a technology or compound, subject to…

Option and evaluation: recent partnering industry trends

The article here analyses the recent partnering industry trends in the option and evaluation deal type areas. There are two major forms of deal terms that allow a party to secure rights to an asset subject to a future event

Current Agreements Deal Analysis Update : December 2014

This month we provide you with an overview of deal analysis in the life science sectors, covering partnering, M&A and financing in November 2014 and give you an exclusive opportunity to gain discounted annual subscription access to our database.

Current Agreements Deal Analysis Update : November 2014

This month we provide you with an overview of deal analysis in the life science sectors, covering partnering, M&A and financing in October 2014.

Current Agreements Deal Analysis Update : October 2014

This month we provide you with an overview of deal analysis in the life science sectors, covering partnering, M&A and financing in September 2014.

Manufacturing and Supply partnering: global trends in pharma industry

The article here analyses the recent manufacturing and supply partnering trends in the pharma industry. A supply or manufacturing agreement is normally between a product manufacturer and product owner in which an owner outsources the manufacture and supply of its product(s) to the service company in a defined territory.

Current Agreements Deal Analysis Update : September 2014

This month we provide you with an overview of life science deal making activity, covering partnering, M&A and financing in August 2014.

Recent industry analysis on distribution partnering agreements

Recent industry analysis gathered from our database Current Agreements, showcases a high volume of dealmaking activity in the distribution deal type among the pharma and biotech companies worldwide.

Abbvie: A new company holding its own in the competitive world of pharma

Abbvie is a global pharmaceutical company developing life saving products for a number of major diseases including immunology.

Events

Sorry, your search returned no results.


Deals

BMS, Ono, Kyowa in nivolumab-ogamulizumab clinical evaluation

Ono Pharmaceutical, Bristol-Myers Squibb Company and Kyowa Hakko Kirin have entered into a clinical trial collaboration agreement to conduct a Phase 1 combination study

Global Green, Inc. Signs Agreement with Merial for Evaluation of Salmonella Vaccine and License Option

Global Green announces the signing of an agreement with Merial to conduct an internal evaluation of Global Green’s patented Salmogenics vaccine technology.

Arrowhead in new antibody evaluation pharma deals with big pharma Merck

Arrowhead Research Corporation announced signing of new pharma deals with Merck, through a subsidiary, to undertake an evaluation of a novel proprietary therapeutic monoclonal antibody candidate derived from Arrowhead’s human-derived peptide targeting and discovery program.

Almac Group to undertake evaluation FLEXYTE protein kinase assays for AstraZeneca

During the evaluation period AstraZeneca will assess the performance of the FLEXYTE™ platform in its laboratories against specific targets of interest.

BMS and Janssen signs a pharma alliance for cancer treatment

BMS, Pharmacyclics and Janssen R&D have started a pharma alliance for Opdivo and Imbruvica evaluation.

Bellicum Pharmaceuticals in $55 million Series C financing

Bellicum Pharmaceuticals today announced the successful completion of a $55M Series C financing.

Viacyte and Janssen sign a pharma deal

ViaCyte has entered into a pharma deal with Janssen Research & Development for VC-01.

AIBioTech receives a $900 million biotech contract

AIBioTech is pleased to announce that it is acting as a subcontractor to Leidos, which was awarded a contract by the U.S. Air Force to provide research, development, testing and evaluation for Homeland Defense and Security Technical Area Tasks (HD TAT) to the Department of Defense (DoD) community of interest.

Novartis announces biotech partnering with Google

Novartis has entered into a biotech partnering agreement with a division of Google to in-license its “smart lens” technology for all ocular medical uses.

AstraZeneca rejects Pfizer’s final offer, again

On Friday May 16th, 2014, Pfizer announces its final proposal to combine the two companies.